Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes (opens ClinicalTrials.gov)

Semaglutide (Wegovy) Treatment for Trichotillomania (opens ClinicalTrials.gov)

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project) (opens ClinicalTrials.gov)

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity (opens ClinicalTrials.gov)

A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) (opens ClinicalTrials.gov)

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) (opens ClinicalTrials.gov)

BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes (opens ClinicalTrials.gov)

A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes (opens ClinicalTrials.gov)

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) (opens ClinicalTrials.gov)

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant (opens ClinicalTrials.gov)

Glutide for Ending Methamphetamine (opens ClinicalTrials.gov)

A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes (opens ClinicalTrials.gov)

BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity (opens ClinicalTrials.gov)

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin (opens ClinicalTrials.gov)

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss (opens ClinicalTrials.gov)

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes (opens ClinicalTrials.gov)

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity (opens ClinicalTrials.gov)

GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis (opens ClinicalTrials.gov)

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial (opens ClinicalTrials.gov)

Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves (opens ClinicalTrials.gov)